the Efficacy and Safety of CLAE in R/R T-ALL/LBL

NCT04679506 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Interventions

DRUG: Cladribine

Sponsor

Peking University Third Hospital